OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
Recruiting now · Not applicable
Conditions studied: ST Elevation Myocardial Infarction, Myocardial Infarction
In brief
The aim of the study is to compare clinical outcomes between optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).
Key facts
- Study ID
- NCT06227754
- Run by
- Chonnam National University Hospital
- People needed
- 1500
- Starts
- 2024-03-25
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2026-05-08
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject must be at least 19 years of age
- Acute ST-segment elevation myocardial infarction (STEMI)
- STEMI: ST-segment elevation ≥0.1 mV in ≥2 contiguous leads or documented newly developed left bundle-branch block1
- Primary percutaneous coronary intervention (PCI) in < 12 h after the onset of symptoms for STEMI patients
- Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic evaluation and PCI and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
You may not qualify if…
- Target lesions not amenable for PCI by operators' decision
- Ostial lesions located in left main vessel or right coronary artery (left main body or distal bifurcation lesions can be enrolled by operator's discretion)
- Creatinine clearance ≤30 ml/min/1.73 m2 and not on dialysis (chronic dialysis dependent patients are eligible for enrolment regardless of creatinine clearance)
- Cardiogenic shock (Killip class IV) at presentation
- Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparin, or Everolimus
- Known true anaphylaxis to contrast medium (not allergic reaction but anaphylactic shock)
- Pregnancy or breast feeding
- Non-cardiac co-morbid conditions are present with life expectancy <2 year or that may result in protocol non-compliance (per site investigator's medical judgment)
- Unwillingness or inability to comply with the procedures described in this protocol
Where it is running
- Daegu Catholic University Medical Center — Daegu, Daegu, South Korea (enrolling)
- Kyungpook National University Hospital — Daegu, Daegu, South Korea (enrolling)
- Yeungnam University Medical Center — Daegu, Daegu, South Korea (enrolling)
- Chonnam National University — Gwangju, Gwangju, South Korea (enrolling)
- Wonkwang University Hospital — Iksan, Iksan, South Korea (enrolling)
- International St. Mary's Hospital — Incheon, Incheon, South Korea (enrolling)
- Jeju National University Hospital — Jeju City, Jeju-do, South Korea (enrolling)
- Jeonbuk National University Hospital — Jeonju, Jeonju, South Korea (enrolling)
- Gyeongsang National University Hospital — Jinju, Jinju, South Korea (enrolling)
- Kyung Hee University Hospital — Seoul, Seoul, South Korea (enrolling)
- Samsung Medical Center — Seoul, Seoul, South Korea (enrolling)
- Chung-Ang University Hospital — Seoul, Seoul, South Korea (enrolling)
- Ewha Womans University Seoul Hospital — Seoul, Seoul, South Korea (enrolling)
- Ewha Womans University Mokdong Hospital — Seoul, Seoul, South Korea (enrolling)
- Korea University Guro Hospital — Seoul, Seoul, South Korea (enrolling)
- St. Carollo Hospital — Suncheon, Suncheon, South Korea (enrolling)
- Uijeongbu St Mary's Hospital — Uijeongbu-si, Uijeongbu, South Korea (enrolling)
- Ulsan University Hospital — Ulsan, Ulsan, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.